Product Program year 2021 Source: CMS Open Payments

Evera

Device Implantable Cardioverter Defibrillators (ICDs)

PDI 00643169720497

Open in the dashboard

General payments

$11,902

374 payments

Research payments

$0

0 payments

Through program year 2021, $11,902 in general payments and $0 in research payments were reported against Evera (Implantable Cardioverter Defibrillators (ICDs)).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $11,902 374

Breakdown

Who paid General payments · program year 2021
  1. Medtronic, Inc. $11,902 374 payments
Top recipients General payments · program year 2021
  1. Mark Marieb Clinical Cardiac Electrophysiology · Hamden, CT $773 6% · 26 payments
  2. Dale Presser Cardiovascular Disease · Covington, LA $316 3% · 18 payments
  3. Eric Taylor Clinical Cardiac Electrophysiology · McAllen, TX $272 2% · 9 payments
  4. Dina Sparano Clinical Cardiac Electrophysiology · Mayfield Heights, OH $224 2% · 2 payments
  5. Nicola Calabrese Nurse Practitioner, Acute Care · Middletown, CT $209 2% · 5 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Clinical Cardiac Electrophysiology Internal Medicine $6,167 53% · 96 practitioners
  2. Cardiovascular Disease Internal Medicine $2,692 23% · 54 practitioners
  3. Interventional Cardiology Internal Medicine $862 7% · 25 practitioners
  4. Thoracic Surgery (Cardiothoracic Vascular Surgery) $404 4% · 2 practitioners
  5. Internal Medicine $390 3% · 4 practitioners

The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Connecticut $1,235 10% · 7 recipients
  2. Florida $1,232 10% · 36 recipients
  3. California $1,152 10% · 25 recipients
  4. New York $1,048 9% · 21 recipients
  5. Texas $1,032 9% · 25 recipients

The top 5 of 31 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

374 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record